Featured Article
Academic Journal
Main Category: Melanoma / Skin Cancer
Also Included In: Preventive Medicine;Â Â Pain / Anesthetics
Article Date: 29 May 2012 - 3:00 PDT
email to a friend  
printer friendly  
opinions  <!-- 
rate article Patient / Public:
Healthcare Prof:
Aspirin and other commonly used painkillers may help guard against skin cancer, according to a new study about to be published online in the journal CANCER, that was led by researchers from Aarhus University Hospital in Denmark.
Previous studies have already suggested that NSAIDs (nonsteroidal anti-inflammatory drugs) such as aspirin, ibuprofen, and naproxen, and other prescription and over the counter drugs, can reduce people's risk of developing some cancers.
In this latest study, Sigrún Alba Jóhannesdóttir and colleagues looked at the effect of these drugs on three major types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.
From medical records covering 1991 to 2009 of people living in northern Denmark, they found diagnoses of 1,974 cases of squamous cell carcinoma, 13,316 of basal cell carcinoma, and 3,242 of malignant melanoma.
The records also had information about prescription drugs, enabling the researchers to compare their use in the people with skin cancer to that of 178,655 people without a skin cancer diagnosis.
The results showed that:
- People with more than 2 prescriptions for NSAIDs has a 15% lower risk for squamous cell carcinoma and a 13% lower risk for malignant melanoma than those with fewer than 2 prescriptions.
- The link was even stronger when the drugs appeared to have been taken for 7 years or more, at a high intensity.
- Taking NSAIDs did not appear to be linked to a lower risk of developing basal cell carcinoma overall.
- But, taking NSAIDs was linked to a lower risk of developing this type of skin cancer in less exposed parts of the body (ie not the head or neck), particularly on a long term (15% reduced risk) or high intensity (21% reduced risk) basis.
"We hope that the potential cancer-protective effect of NSAIDs will inspire more research on skin cancer prevention."
"Also, this potential cancer-protective effect should be taken into account when discussing benefits and harms of NSAID use," she added.
Basal cell carcinoma is a type of nonmelanoma skin cancer that grows slowly and painlessly and rarely spreads. It is the most common form of cancer in the US. According to the American Cancer Society, 75% of all skin cancers are basal cell carcinomas. Squamous cell carcinoma is also a nonmelanoma type and grows a bit faster than basal cell carcinoma. Both of these types of nonmelanoma skin cancer are treatable.
Melanoma is the most dangerous type of skin cancer and can spread to other parts of the body very quickly. Some cases can be cured if caught very early. Melanoma is the leading cause of death from skin disease.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
APA
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Aspirin May Guard Against Skin Cancer'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
back to top | home | privacy policy
MediLexicon International LtdBexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.
Tidak ada komentar:
Posting Komentar